AP NEWS

Ultralife Corporation Reports Fourth Quarter Results

February 7, 2019

NEWARK, N.Y., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $1.1 million on revenue of $20.9 million for the fourth quarter ended December 31, 2018 compared to operating income of $2.1 million on revenue of $22.5 million for the fourth quarter of 2017. For fiscal year 2018, Ultralife produced operating income of $6.6 million on revenue of $87.2 million compared to operating income of $6.5 million on revenue of $85.5 million for 2017.

“During the fourth quarter our Battery and Energy Products revenue grew 8% year-over-year from increases in both our commercial and government defense markets, with medical sales up 14%. However, at Communications Systems, after four consecutive quarters of double digit revenue growth, fourth quarter sales decreased year-over-year due to modifications to production and initial shipment schedules under the $19 million in delivery contracts received in October 2018 for the U.S. Army. Shipments are now anticipated to begin in the first quarter of 2019,” said Michael D. Popielec, President and Chief Executive Officer. “The opportunities for growth in 2019 from our commercial diversification strategy and government/defense customers remain strong, and we have started the new fiscal year with over $50 million in backlog, a 30% increase over the beginning of 2018. As a result of this starting point, other new revenue opportunities, and continued operating expense discipline, we expect to deliver profitable growth in 2019.”

Fourth Quarter 2018 Financial Results

Revenue was $20.9 million, a decrease of $1.6 million, or 7%, compared to $22.5 million for the fourth quarter of 2017. Battery & Energy Products sales increased 8% to $18.2 million compared to $16.8 million last year due primarily to a 13% increase in commercial sales reflecting higher shipments to medical customers and a 2% increase in government/defense sales. Communications Systems sales declined 51% from $5.7 million in the 2017 period to $2.8 million due primarily to higher shipments of Vehicle Amplifier-Adaptors to fulfill contracts in the fourth quarter of 2017.

Gross profit was $5.7 million, or 27.3% of revenue, compared to $6.9 million, or 30.5% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin was 27.0% compared to 28.6% last year, and Communications Systems’ gross margin was 28.8% compared to 36.2% last year. The gross margin decrease was primarily due to sales mix.

Operating expenses were $4.6 million compared to $4.8 million last year reflecting continued tight control over discretionary spending. Operating expenses were 22.2% of revenue compared to 21.4% of revenue for the year earlier period.

Operating income was $1.1 million compared to $2.1 million last year for an operating margin of 5.1% compared to 9.1% last year.

Net income was $19.7 million, which includes a non-cash tax benefit of $18.7 million upon the release of the valuation allowance on our U.S. deferred tax assets based on management’s assessment of a number of factors including anticipated future sustained profitability of our business, compared to $3.8 million for 2017, which included a non-cash tax benefit of $1.9 million resulting from the Tax Cuts and Jobs Act. Reported earnings per share for the fourth quarter of 2018 were $1.24 which includes $0.07 from our operating performance plus $1.17 related to the tax benefit, compared to $0.24 for the fourth quarter of 2017 which included $0.12 from our operating performance plus $0.12 related to the tax benefit. Earnings per share for the full year of $1.57 include $0.40 per share from our 2018 operating performance compared to $0.49 which included $0.37 per share from our 2017 operating performance.

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense, of $9.9 million for 2018, or 11.4% of sales, grew 3% over the $9.6 million, or 11.2% of sales, reported last year.

See the “Non-GAAP Financial Measure – Adjusted EBITDA” section of this release for a reconciliation of Adjusted EBITDA to Net Income Attributable to Ultralife Corporation.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company’s business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

Conference Call Information

Ultralife will hold its fourth quarter earnings conference call today at 10:00 AM ET. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company’s website at https://investor.ultralifecorporation.com/. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: potential reductions in revenues from key customers, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company’s analysis only as of today’s date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

ULTRALIFE CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Dollars in Thousands) (Unaudited) ASSETS December 31, December 31, 2018 2017 ------------ - ------------ - Current Assets: Cash $25,934 $18,330 Trade Accounts Receivable, Net 16,015 14,657 Inventories 22,843 26,326 Prepaid Expenses and Other Current Assets 2,429 2,603 Total Current Assets 67,221 61,916 Property, Equipment and Improvements, Net 10,744 7,570 Deferred Income Taxes, Net 15,444 32 Goodwill, Intangibles and Other Assets 26,695 27,668 Total Assets $120,104 $97,186 ------------- - ------------- - LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities: Accounts Payable $9,919 $8,787 Accrued Compensation and Related Benefits 1,494 2,413 Accrued Expenses and Other Current Liabilities 3,534 3,039 Total Current Liabilities 14,947 14,239 Deferred Income Taxes, Net and Other Non-Current Liabilities 623 3,898 Total Liabilities 15,570 18,137 ------------ - ------------ - Shareholders’ Equity: Common Stock 2,005 1,966 Capital in Excess of Par Value 182,630 180,211 Accumulated Deficit (57,964 ) (82,894 ) Accumulated Other Comprehensive Loss (2,786 ) (1,611 ) Treasury Stock (19,266 ) (18,469 ) ------------ - ------------ - Total Ultralife Equity 104,619 79,203 Non-Controlling Interest (85 ) (154 ) ------------ - ------------ - Total Shareholders’ Equity 104,534 79,049 ------------ - ------------ - Total Liabilities and Shareholders’ Equity $120,104 $97,186 ------------- - ------------- -

ULTRALIFE CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME (Dollars in Thousands, Except Per Share Amounts) (Unaudited) Three-Month Periods Ended Year Ended December 31, December 31, December 31, December 31, 2018 2017 2018 2017 ------------ - ------------ - ------------ - ------------ - Revenues: Battery & Energy Products $18,153 $16,812 $70,497 $69,789 Communications Systems 2,774 5,697 16,693 15,742 ------------ - ------------ - ------------ - ------------ - Total Revenues 20,927 22,509 87,190 85,531 ------------ - ------------ - ------------ - ------------ - Cost of Products Sold: Battery & Energy Products 13,243 12,011 50,923 50,130 Communications Systems 1,974 3,632 10,684 9,169 ------------ - ------------ - ------------ - ------------ - Total Cost of Products Sold 15,217 15,643 61,607 59,299 ------------ - ------------ - ------------ - ------------ - Gross Profit 5,710 6,866 25,583 26,232 ------------ - ------------ - ------------ - ------------ - Operating Expenses: Research and Development 1,092 1,059 4,508 4,737 Selling, General and Administrative 3,551 3,757 14,520 15,019 Total Operating Expenses 4,643 4,816 19,028 19,756 ------------ - ------------ - ------------ - ------------ - Operating Income 1,067 2,050 6,555 6,476 Other (Income) Expense (85 ) (19 ) (58 ) 181 Income Before Income Taxes 1,152 2,069 6,613 6,295 Income Tax (Benefit) (18,605 ) (1,739 ) (18,386 ) (1,369 ) ------------ - ------------ - ------------ - ------------ - Net Income 19,757 3,808 24,999 7,664 Net Income Attributable to Non-Controlling 12 8 69 16 Interest ------------ - ------------ - ------------ - ------------ - Net Income Attributable to Ultralife $19,745 $3,800 $24,930 $7,648 Corporation ------------- - ------------- - ------------- - ------------- - Other Comprehensive (Loss) Income: Foreign Currency Translation Adjustments (310 ) 716 (1,175 ) 1,469 ------------ - ------------ - ------------ - ------------ - Comprehensive Income Attributable to $19,435 $4,516 23,755 $9,117 Ultralife Net Income Per Share Attributable to $1.24 $.24 $1.57 $.49 Ultralife Common Shareholders – Basic ------------- - ------------ - ------------- - ------------ - Net Income Per Share Attributable to $1.21 $.24 $1.53 $.48 Ultralife Common Shareholders – Diluted ------------- - ------------ - ------------- - ------------ - Weighted Average Shares Outstanding – Basic 15,950 15,657 15,882 15,528 ------------ - ------------ - ------------ - ------------ - Weighted Average Shares Outstanding – 16,292 16,031 16,347 15,858 Diluted ------------ - ------------ - ------------ - ------------ -

Non-GAAP Financial Measure – Adjusted EBITDA

In evaluating our business, we consider and use Adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance. We define Adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision (benefit) for income taxes, depreciation and amortization, and stock-based compensation expense. We reconcile Adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). Neither current nor potential investors in our securities should rely on Adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of Adjusted EBITDA to net income attributable to Ultralife.

ULTRALIFE CORPORATION AND SUBSIDIARIES CALCULATION OF ADJUSTED EBITDA (Dollars in Thousands) (Unaudited) Three-Month Periods Ended Year Ended December 31, December 31, December 31, December 31, 2018 2017 2018 2017 ------------ - ------------ - ------------ - ------------ - Net Income Attributable to Ultralife $19,745 $3,800 $24,930 $7,648 Corporation Adjustments: Interest and Financing (Income) Expense, (4 ) 36 63 183 Net Income Tax (Benefit) (18,605 ) (1,739 ) (18,386 ) (1,369 ) Depreciation Expense 496 494 1,972 2,005 Amortization of Intangible Assets and 106 116 433 474 Financing Fees Stock-Based Compensation Expense 183 124 890 653 Adjusted EBITDA $1,921 $2,831 $9,902 $9,594 ------------- - ------------- - ------------- - ------------- -

Company Contact:Ultralife CorporationPhilip A. Fain(315) 210-6110 pfain@ulbi.com

Investor Relations Contact:LHAJody Burfening(212) 838-3777 jburfening@lhai.com

AP RADIO
Update hourly